Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Shares Outstanding (2016 - 2025)

Fortress Biotech has reported Shares Outstanding over the past 13 years, most recently at $31.4 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $31.4 million for Q4 2025, up 12.38% from a year ago — trailing twelve months through Dec 2025 was $31.4 million (up 12.38% YoY), and the annual figure for FY2025 was $31.4 million, up 12.38%.
  • Shares Outstanding for Q4 2025 was $31.4 million at Fortress Biotech, up from $31.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding for FBIO hit a ceiling of $668.8 million in Q3 2022 and a floor of $365000.0 in Q3 2021.
  • Median Shares Outstanding over the past 5 years was $23.5 million (2024), compared with a mean of $61.6 million.
  • Biggest five-year swings in Shares Outstanding: crashed 99.61% in 2021 and later soared 183119.45% in 2022.
  • Fortress Biotech's Shares Outstanding stood at $6.8 million in 2021, then grew by 8.93% to $7.4 million in 2022, then skyrocketed by 104.89% to $15.1 million in 2023, then surged by 84.91% to $27.9 million in 2024, then rose by 12.38% to $31.4 million in 2025.
  • The last three reported values for Shares Outstanding were $31.4 million (Q4 2025), $31.0 million (Q3 2025), and $29.8 million (Q2 2025) per Business Quant data.